Biopharmaceutical firm Cytogen of Princeton, NJ, said it is likely to join the Russell 3000 Index, according to a preliminary list of additions issued by Russell Investment Group.
Biopharmaceutical firm Cytogen of Princeton, NJ, said it is likely to join the Russell 3000 Index, according to a preliminary list of additions issued by Russell Investment Group. The Russell 3000 Index will be reconstituted June 25. Membership in the Russell 3000 means automatic inclusion in either the large-cap Russell 1000 Index or small-cap Russell 2000 Index.
By AuntMinnie.com staff writersJune 14, 2004
Related Reading
Cytogen to raise $26 million in stock sale, April 16, 2004
Cytogen adds to management team, April 9, 2004
Cytogen makes $20.5 million stock placement, November 10, 2003
Higher revenues cut Cytogen loss, November 5, 2003
Cytogen signs Whitey Ford, September 5, 2003
Copyright © 2004 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
